Related Experiment Video
Updated: Apr 21, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.2K
Dynamic simulation of motion effects in IMAT lung SBRT
Radiation Oncology (London, England)
|November 5, 2014
Summary
Intensity modulated arc therapy (IMAT) for lung cancer SBRT showed minimal target dose variation. However, critical organs near the tumor experienced significant dose deviations due to interplay effects.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment
Background:
- Intensity modulated arc therapy (IMAT) is standard for lung cancer Stereotactic Body Radiotherapy (SBRT).
- Dose optimization typically uses static CT, potentially causing discrepancies between planned and delivered radiation due to motion interplay.
- Investigating these dosimetric consequences is crucial for accurate treatment.
Purpose of the Study:
- To evaluate the dosimetric impact of interplay effects in lung cancer SBRT using dynamic CT simulations.
- To compare dose delivery accuracy between static and dynamic simulations for planning and Intensity modulated arc therapy.
Main Methods:
- Retrospective analysis of 15 Stage I NSCLC patients undergoing SBRT (50 Gy/4 fractions).
- Dynamic dose delivery was simulated using 4D-CT data and machine log files.
- Dose accumulation and comparison with static CT-based plans were performed.
Main Results:
- Planning Target Volume (PTV) dose coverage showed <1.5% variation between static and dynamic simulations.
- Average inter-fraction and cumulative dosimetric effects were minimal (<0.5% for PTV coverage, <0.8 Gy for OARs).
- Significant dose variations (up to 7.8 Gy) were observed in organs near the target, such as great vessels and the bronchus.
Conclusions:
- Lung cancer SBRT with IMAT demonstrates limited dose variation for target coverage and OAR constraints under dynamic conditions.
- Critical organs adjacent to the tumor are susceptible to substantial dose variations due to interplay effects.
- Dynamic simulation is essential for accurately assessing dose delivery in SBRT, especially for tumors near critical structures.

